Emerald Health Therapeutics Inc (EMH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 834 | 1,816 | 2,275 | 2,105 | 3,044 |
| Cost of Goods | 751 | 2,892 | 6,892 | 2,634 | 3,351 |
| Gross Profit | 83 | -1,076 | -4,617 | -529 | -307 |
| Operating Expenses | 2,279 | 2,207 | 2,782 | 3,866 | 4,105 |
| Operating Income | -2,196 | -3,283 | -7,399 | -4,395 | -4,412 |
| Interest Expense | 901 | 874 | 670 | 11 | 31 |
| Other Income | 1,234 | 840 | -5,098 | -4,738 | -9,513 |
| Pre-tax Income | -1,863 | -3,317 | -13,167 | -9,144 | -13,956 |
| Net Income Continuous | -1,863 | -3,317 | -13,167 | -9,144 | -13,956 |
| Net Income | $-1,863 | $-3,317 | $-13,167 | $-9,144 | $-13,956 |
| EPS Basic Total Ops | -0.01 | -0.02 | -0.07 | -0.04 | -0.07 |
| EPS Basic Continuous Ops | -0.01 | -0.02 | -0.07 | -0.04 | -0.07 |
| EPS Diluted Total Ops | -0.01 | -0.02 | -0.07 | -0.04 | -0.07 |
| EPS Diluted Continuous Ops | -0.01 | -0.02 | -0.07 | -0.04 | -0.07 |
| EBITDA(a) | $-905 | $-2,439 | $-11,801 | $-8,676 | $-13,078 |